发明名称 |
Therapeutic interleukin-2-antibody based fusion proteins |
摘要 |
The present invention relates to antibody-based fusion proteins wherein a portion of an immunoglobulin molecule is linked to a biologically active ligand. In particular embodiments of the invention, the fusion protein comprises a portion of an antibody which recognizes a cell surface antigen linked to a ligand which is a lymphokine or a cellular factor. A preferred embodiment of the fusion protein comprises the variable region of the anti-tumor monoclonal antibody L6 and an active lymphokine molecule such as IL-2. In another preferred embodiment of the present invention, the fusion protein comprises the variable region of the L6 monoclonal antibody and active platelet factor 4. The antibody-based fusion proteins of the invention may be used therapeutically to deliver biologically active ligands to a specific target cell or tissue.
|
申请公布号 |
US5314995(A) |
申请公布日期 |
1994.05.24 |
申请号 |
US19900468390 |
申请日期 |
1990.01.22 |
申请人 |
ONCOGEN |
发明人 |
FELL, JR., HENRY P.;GAYLE, MARGIT A. |
分类号 |
A61K38/00;A61K39/395;A61K47/48;A61P35/00;C07K14/00;C07K14/46;C07K14/52;C07K14/54;C07K14/55;C07K16/00;C07K16/30;C07K16/46;C07K19/00;C12N15/09;C12P21/02;C12P21/08;C12R1/91;(IPC1-7):C07K13/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|